Healthcare
Helix BioPharma Corp. Announces Fiscal 2026 Year-End Results
Vancouver, British Columbia – TheNewswire - October 29, 2026 – Helix BioPharma Corp. (TSX: “HBP”, OTC: “HBPCF”, FRANKFURT: “HBP0”) ( “Helix” or the “Company” ), a clinical-stage oncology company developing…
